UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of chemo-response in serous ovarian cancer

Molecular cancer, 2016-10, Vol.15 (1), p.66-66, Article 66

2016

Volltextzugriff (PDF)

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

Clinical and translational medicine, 2023-05, Vol.13 (5), p.e1223-n/a

2023

Volltextzugriff (PDF)

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1205

2019

Volltextzugriff (PDF)

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Molecular cancer, 2014-05, Vol.13 (1), p.129-129, Article 129

2014

Volltextzugriff (PDF)

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

Gynecologic oncology, 2009-07, Vol.114 (1), p.3-11

2009

Volltextzugriff (PDF)

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Oncology letters, 2021-10, Vol.22 (4), p.1, Article 733

2021

Volltextzugriff (PDF)

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

International journal of molecular sciences, 2022-12, Vol.23 (24), p.16014

2022

Volltextzugriff (PDF)

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4791

2021

Volltextzugriff (PDF)

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

Cancers, 2021-03, Vol.13 (5), p.1109

2021

Volltextzugriff (PDF)

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1175

2019

Volltextzugriff (PDF)

Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1192

2019

Volltextzugriff (PDF)

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers

International journal of oncology, 2017-05, Vol.50 (5), p.1721-1728

2017

Volltextzugriff (PDF)

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options

PloS one, 2021-01, Vol.16 (1), p.e0245664-e0245664

2021

Volltextzugriff (PDF)

Role of metadherin in estrogen-regulated gene expression

International journal of molecular medicine, 2017-08, Vol.40 (2), p.303-310

2017

Volltextzugriff (PDF)

Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation

Journal of assisted reproduction and genetics, 2016-08, Vol.33 (8), p.1017-1025

2016

Volltextzugriff (PDF)

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

American journal of obstetrics and gynecology, 2013-12, Vol.209 (6), p.576.e1-576.e16

2013

Volltextzugriff (PDF)

The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes

OncoTargets and therapy, 2018-01, Vol.11, p.7205-7211

2018

Volltextzugriff (PDF)

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior

Scientific reports, 2019-11, Vol.9 (1), p.17996-13, Article 17996

2019

Volltextzugriff (PDF)

Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer

International journal of gynecological cancer, 2018-02, Vol.28 (2), p.260-266

2018

Volltextzugriff (PDF)

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (19), p.7933-7938

2009

Volltextzugriff (PDF)

Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data

International journal of gynecological cancer, 2015-07, Vol.25 (6), p.1000-1009

2015

Volltextzugriff (PDF)

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

Oncology reports, 2014-01, Vol.31 (1), p.376-383

2014

Volltextzugriff (PDF)

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Oncology reports, 2013-05, Vol.29 (5), p.2011-2018

2013

Volltextzugriff (PDF)

Characterizing the Efficacy of Fermented Wheat Germ Extract Against Ovarian Cancer and Defining the Genomic Basis of Its Activity

International journal of gynecological cancer, 2012-07, Vol.22 (6), p.960-967

2012

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaGene Expression

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prediction of chemo-response in serous ovarian cancer

FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways

A Prediction Model for Preoperative Risk Assessment in Endometrial Cancer Utilizing Clinical and Molecular Variables

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer

A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo‑response in high‑grade serous ovarian cancer

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer

Population Substructure Has Implications in Validating Next-Generation Cancer Genomics Studies with TCGA

p53 mutation status is a primary determinant of placenta-specific protein 1 expression in serous ovarian cancers

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options

Role of metadherin in estrogen-regulated gene expression

Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation

Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer

The miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genes

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior

Multiple loci identified in a genome-wide association study of prostate cancer

Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

Prediction of Optimal Cytoreductive Surgery of Serous Ovarian Cancer With Gene Expression Data

Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

Characterizing the Efficacy of Fermented Wheat Germ Extract Against Ovarian Cancer and Defining the Genomic Basis of Its Activity

Aktive Filter

Suchergebnisse filtern